| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |